Expression of RPL32 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPL32 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 2616.09

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

2107.2

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	5375.2
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	5170.3
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	4810.9
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	4286.3
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	4056.2
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	3955.3
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	3863.4
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	3796.6
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	3788.9
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	3623.6
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	3596.4
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	3395.0
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	3240.1
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	3177.0
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	3149.0
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	3040.9
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	2992.1
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	2858.1
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	2854.0
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	2847.2
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	2835.7
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	2819.9
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	2773.6
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	2750.4
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	2717.7
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	2690.6
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	2682.2
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	2657.2
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	2616.1
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	2595.7
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	2563.8
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	2562.6
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	2561.1
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	2533.3
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	2525.6
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	2525.0
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	2487.3
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	2474.9
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	2454.1
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	2432.1
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	2414.1
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	2388.6
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	2301.1
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	2295.9
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	2291.4
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	2284.5
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	2239.2
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	2210.8
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	2194.1
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	2184.3
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	2150.5
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	2145.4
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	2142.7
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	2099.7
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	2096.9
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	2090.8
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	2076.5
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	2055.0
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	2038.5
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	2032.8
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	2020.4
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	2011.4
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	1988.3
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	1967.9
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	1967.6
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	1962.9
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	1939.4
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	1925.6
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	1913.1
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	1904.2
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	1872.2
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	1863.7
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	1858.3
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	1851.0
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	1841.9
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	1841.8
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	1830.0
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	1810.2
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	1799.0
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	1798.1
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	1794.4
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	1788.4
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	1776.6
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	1772.9
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	1769.2
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	1761.7
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	1759.5
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	1747.5
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	1740.8
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	1717.3
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	1702.0
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	1701.6
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	1669.1
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	1659.5
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	1658.7
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	1649.7
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	1633.3
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	1630.0
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	1616.1
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	1608.5
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	1595.4
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	1584.9
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	1552.1
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	1545.3
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	1543.6
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	1541.3
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	1540.0
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	1536.0
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	1531.6
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	1529.2
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	1518.6
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	1515.8
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	1505.0
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	1504.0
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	1494.8
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	1453.1
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	1430.6
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	1414.6
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	1410.8
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	1385.5
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	1385.3
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	1363.3
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	1349.9
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	1349.2
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	1338.2
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	1333.1
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	1320.8
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	1283.4
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	1282.8
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	1252.6
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	1236.1
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	1223.1
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	1180.9
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	1141.7
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	1128.2
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	1121.7
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	1107.2
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	1044.0
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	952.0
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	828.1
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	777.7
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

RPL32 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 549.49

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

515.2

Number of samples

Samples

Sample	Description	pTPM
AK043	N, NA, stage:NA, alive, 660 days	1104.8
AK124	N, NA, stage:NA, alive, 1920 days	1031.6
AK142	N, NA, stage:NA, alive, 90 days	945.6
AK133	N, NA, stage:NA, dead, 360 days	873.2
AK066	N, NA, stage:NA, alive, 960 days	838.7
AK165	N, NA, stage:NA, alive, 360 days	792.2
AK002	N, NA, stage:NA, dead, 570 days	789.3
AK213	N, NA, stage:NA, alive, 2010 days	753.9
AK051	N, NA, stage:NA, dead, 360 days	751.3
AK183	N, NA, stage:NA, alive, 360 days	738.1
AK049	N, NA, stage:NA, dead, 180 days	716.2
AK236	N, NA, stage:NA, dead, 360 days	638.8
AK139	N, NA, stage:NA, dead, 270 days	635.6
AK072	N, NA, stage:NA, dead, 150 days	614.4
AK041	N, NA, stage:NA, alive, 810 days	602.6
AK178	N, NA, stage:NA, dead, 240 days	592.0
AK199	N, NA, stage:NA, alive, 1860 days	567.4
AK173	N, NA, stage:NA, dead, 180 days	531.6
AK074	N, NA, stage:NA, alive, 300 days	516.0
AK055	N, NA, stage:NA, dead, 240 days	514.1
AK195	N, NA, stage:NA, dead, 390 days	513.6
AK231	N, NA, stage:NA, dead, 240 days	513.3
AK134	N, NA, stage:NA, dead, 360 days	500.6
AK185	N, NA, stage:NA, alive, 330 days	494.9
AK149	N, NA, stage:NA, dead, 420 days	492.3
AK205	N, NA, stage:NA, dead, 120 days	490.2
AK156	N, NA, stage:NA, dead, 330 days	484.2
AK098	N, NA, stage:NA, dead, 660 days	479.6
AK071	N, NA, stage:NA, dead, 540 days	472.7
AK123	N, NA, stage:NA, dead, 180 days	462.5
AK158	N, NA, stage:NA, dead, 360 days	456.6
AK153	N, NA, stage:NA, dead, 240 days	443.3
AK053	N, NA, stage:NA, dead, 300 days	441.2
AK188	N, NA, stage:NA, alive, 420 days	432.2
AK103	N, NA, stage:NA, alive, 1320 days	426.5
AK088	N, NA, stage:NA, dead, 360 days	425.5
AK030	N, NA, stage:NA, dead, 120 days	419.4
AK085	N, NA, stage:NA, alive, 660 days	410.4
AK015	N, NA, stage:NA, alive, 720 days	409.8
AK218	N, NA, stage:NA, dead, 180 days	404.4
AK100	N, NA, stage:NA, alive, 960 days	397.9
AK076	N, NA, stage:NA, alive, 660 days	391.8
AK216	N, NA, stage:NA, dead, 360 days	389.1
AK089	N, NA, stage:NA, dead, 330 days	388.0
AK003	N, NA, stage:NA, dead, 600 days	385.3
AK117	N, NA, stage:NA, dead, 210 days	379.2
AK167	N, NA, stage:NA, dead, 180 days	376.8
AK102	N, NA, stage:NA, alive, 1740 days	373.8
AK081	N, NA, stage:NA, dead, 180 days	367.8
AK079	N, NA, stage:NA, dead, 210 days	365.2
AK035	N, NA, stage:NA, dead, 210 days	363.0
AK227	N, NA, stage:NA, alive, 300 days	348.6
AK091	N, NA, stage:NA, dead, 210 days	319.9
AK099	N, NA, stage:NA, dead, 420 days	306.7
AK226	N, NA, stage:NA, dead, 360 days	281.3
AK068	N, NA, stage:NA, alive, 360 days	270.6
AK005	N, NA, stage:NA, dead, 240 days	265.1
AK006	N, NA, stage:NA, dead, 360 days	194.9
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0218330004	Tumor	1.0
CPT0168080003	Tumor	0.9
CPT0182580003	Tumor	0.9
CPT0206560003	Tumor	0.9
CPT0218830004	Tumor	0.9
CPT0218690004	Tumor	0.8
CPT0093510003	Tumor	0.8
CPT0217430008	Tumor	0.8
CPT0224390004	Tumor	0.7
CPT0206000004	Tumor	0.7
CPT0217710008	Tumor	0.7
CPT0206670004	Tumor	0.7
CPT0093450003	Tumor	0.6
CPT0189750004	Tumor	0.6
CPT0162100003	Tumor	0.6
CPT0225760003	Tumor	0.5
CPT0207090003	Tumor	0.5
CPT0093590003	Tumor	0.5
CPT0217000004	Tumor	0.5
CPT0127480003	Tumor	0.5
CPT0161730003	Tumor	0.5
CPT0125510003	Tumor	0.5
CPT0168480003	Tumor	0.4
CPT0078580003	Tumor	0.4
CPT0206230003	Tumor	0.4
CPT0171580008	Tumor	0.4
CPT0217100003	Tumor	0.4
CPT0190360004	Tumor	0.4
CPT0228220003	Tumor	0.4
CPT0224540004	Tumor	0.4
CPT0089150003	Tumor	0.4
CPT0225730003	Tumor	0.3
CPT0162020003	Tumor	0.3
CPT0079790003	Tumor	0.3
CPT0217060003	Tumor	0.3
CPT0208980003	Tumor	0.3
CPT0205570003	Tumor	0.3
CPT0219080004	Tumor	0.3
CPT0002410011	Tumor	0.2
CPT0167640003	Tumor	0.2
CPT0123530003	Tumor	0.2
CPT0093360003	Tumor	0.2
CPT0205670004	Tumor	0.2
CPT0125570003	Tumor	0.2
CPT0205450004	Tumor	0.2
CPT0224600003	Tumor	0.2
CPT0189570004	Tumor	0.2
CPT0087680003	Tumor	0.2
CPT0205780003	Tumor	0.1
CPT0206780003	Tumor	0.1
CPT0168830003	Tumor	0.1
CPT0168380003	Tumor	0.1
CPT0167860004	Tumor	0.1
CPT0221180003	Tumor	0.1
CPT0207030003	Tumor	0.1
CPT0167970003	Tumor	0.0
CPT0087950003	Tumor	0.0
CPT0087570003	Tumor	0.0
CPT0093550003	Tumor	0.0
CPT0168590003	Tumor	0.0
CPT0127420003	Tumor	0.0
CPT0167530003	Tumor	0.0
CPT0217190003	Tumor	-0.1
CPT0168720003	Tumor	-0.1
CPT0217880003	Tumor	-0.1
CPT0064650003	Tumor	-0.1
CPT0167750004	Tumor	-0.1
CPT0182500003	Tumor	-0.1
CPT0168270003	Tumor	-0.1
CPT0182550003	Tumor	-0.1
CPT0206880003	Tumor	-0.2
CPT0092440003	Tumor	-0.2
CPT0218960004	Tumor	-0.2
CPT0189850004	Tumor	-0.2
CPT0218890004	Tumor	-0.2
CPT0201710003	Tumor	-0.2
CPT0175060003	Tumor	-0.2
CPT0064890003	Tumor	-0.2
CPT0206110003	Tumor	-0.3
CPT0087730003	Tumor	-0.3
CPT0206450003	Tumor	-0.3
CPT0216920008	Tumor	-0.3
CPT0071100003	Tumor	-0.3
CPT0186100003	Tumor	-0.4
CPT0209440003	Tumor	-0.4
CPT0162140003	Tumor	-0.4
CPT0224330003	Tumor	-0.4
CPT0204400003	Normal	-0.5
CPT0204360003	Normal	-0.5
CPT0125220003	Tumor	-0.5
CPT0204340003	Normal	-0.5
CPT0205890003	Tumor	-0.5
CPT0218770003	Tumor	-0.5
CPT0206330003	Tumor	-0.5
CPT0104330003	Tumor	-0.5
CPT0190240004	Tumor	-0.5
CPT0189250003	Tumor	-0.5
CPT0104220003	Tumor	-0.5
CPT0204390003	Normal	-0.5
CPT0199770003	Tumor	-0.6
CPT0189650004	Tumor	-0.6
CPT0189460003	Tumor	-0.6
CPT0196850003	Tumor	-0.6
CPT0204410003	Normal	-0.6
CPT0218670003	Tumor	-0.6
CPT0204330003	Normal	-0.7
CPT0204370003	Normal	-0.7
CPT0204350003	Normal	-0.7
CPT0204380003	Normal	-0.8
CPT0204420003	Normal	-0.9
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA047501	Antibody HPA051994
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, Low grade